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Abstract.   Human peripheral blood mononuclear cells (PBMCs) activated with Con-A release
a soluble factor which augments the expression of class I major histocompatibility complex 
(MHC) antigens by a variety of tumour cells. Previous attempts to purify this factor called 
MHC-activating factor (AF) (MHC-AF) made us realize that the presence of large numbers and 
quantities of irrelevant fetal calf serum proteins in the culture supernatants of the activated 
human PBMCs, interfered with the purification procedure. It was therefore necessary to 
standardize the use of a serum free culture medium to generate human MHC-AF. In the present 
communication we have tried several types of culture media and have identified DCCM-2 
as the most suitable culture medium to generate human MHC-AF. MHC-AF generated 
in DCCM-2 medium appears to be a protein molecule resistant to pH 2 treatment but sensitive 
to heat treatment (56°C × 45 min) and treatment with proteolytic enzymes trypsin and 
chymotrypsin. 
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1. Introduction 
 
We have previously shown that mitogen activated human peripheral blood lym-
phocytes (HPBLs) secrete a factor which augments the expression of class I MHC 
antigens on tumour cells (Saxena et al 1992,1996). Our attempts to purify this factor 
were hampered by the presence of large quantities of fetal calf serum derived irrelevant 
proteins present in the culture medium used to activate the PBLs (Saxena et al 1996). In 
order to devise a suitable purification strategy, it was necessary to activate HPBLs in 
serum free culture medium. In the present study, we have attempted to define culture 
conditions for generating human MHC-AF in culture media containing low levels of 
protein. Culture media examined for this purpose included RPMI-1640 medium alone 
or supplemented with 5% fetal calf serum (FCS) (control), 2% FCS or 1 mg/ml BS A. 
Two commercially available serum free media DCCM-1 and DCCM-2 were also 
examined. Our result indicate that DCCM-2 medium which had the minimum amount 
 of proteins (126 µg/ml of defined proteins) supported significant levels of mitogen 
induced proliferation of HPBLs. MHC-AF was found to be released by activated 
HPBLs in DCCM-2 medium, as assessed by augmentation of MHC I antigens on HR 
tumour cells. Unlike IFN-y, MHC-AF produced in DCCM-2 medium, was resistant to
pH 2·0 treatment. Upon concentration on Amicon 30Κ membrane, most MHC-AF
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activity was retained, indicating that the molecular weight of MHC-AF could be above 
30K. Human MHC-AF was also found to be sensitive to heat treatment and is 
deactivated by treatment with proteolytic enzymes. 
 
 
2.   Materials and methods
 
2.1    Culture medium 
 
Several types of culture media were used in this study. Tumour cell lines were 
maintained in RPMM64O from Sigma, supplemented with 5% FCS, 2 × 10–5 Μ 2- 
mercaptaethanol (ME), 300µg/ml glutamine, and 6Oµg/ml gentamicin (complete 
medium). For proliferation assay, RPMI-1640 was supplemented with either 5% FCS, 
2% FCS or lmg/ml BS A. Two commercially available serum free media, DCCM-1 and 
DCCM-2 from Biological Industries, Israel, were also used for proliferation assay 
and for generating human MHC-AF. 
 
 
 
2. 2   Preparation of  crude human MHC-AF 
 
Human peripheral blood lymphocytes (HPBLs) were derived from blood from normal 
donors (Red Cross Society, New Delhi, Courtsey Dr Μ L Gupta), by Ficoll Hypaque 
density gradient centrifugation at 200 g for 30 min. Cells were washed three times with 
ice cold PBS, suspended in culture media at 5×106/ml and cultured for 3 days with 
Con-A (5 mg/ml). After 3 days the supernatant was collected by centrifugation at 400 g 
for 20 min. The proteins in the supernatant were precipitated by adding 599 g/liter of 
ammonium sulphate (4°C overnight). The precipitated proteins were pelleted by 
centrifugation at 10,000 g for 20 min., resuspended in deionized water, dialyzed against 
0·1 Μ glycine-HCl buffer, pH 2·0 for two days with three changes and then neutralized 
to pH 7·0 by using 1O Ν NaOH. Any insoluble material at this stage was removed by 
centrifugation. If required the solution was concentrated by using a 30 Κ Amicon 
membrane filter. 
 
 
 
2.3 Estimation of cell surface antigen on tumour cell lines 
 
The tumour cells were cultured at 3 × 105 cells/ml in RPMI-1640 culture medium 
supplemented with 10% FCS, in the presence ofdesired concentration of the test agents 
for 2 to 3 days, in 96 Dell flat bottomed culture plates. At the end of the incubation, the 
cells were harvested and stained for class IMHC antigens (Saxena et al 1996). Culture 
supernatants of HB95 hybridoma were used as a source of a mouse monoclonal 
antibody reactive to a non-polymorphic region of class I MHC antigens in case of 
human cell lines. Control or treated cells were suspended in 50 µl of respective 
hybridoma supernatants and incubated for 20 min at 4°C. Cells were washed once with
cold PBS and suspended in 50 µl of rabbit anti mouse Ig FITC at 1:400 dilution. After
20 min incubation at 4°C, cells were washed once with cold PBS and fixed in 0.5 ml of
1% (w/v) paraformaldehyde in PBS. Stained and fixed cells were analysed on a flow-
cytometer (Coulter Epics XL model). 
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2.4 Proliferation assay 
 
HPBLs were cultured in 5 different media, RPMI-1640 + 2% FCS, RPMI-
1640+ lmg/ml BSA, RPMI-1640 + 5% FCS, DCCM-1 and DCCM-2, at 2 × 105 
cells/ml, alone or with Con-A (2 µg/ml) or PHA (2 µg/m1) in 96 well flat bottomed 
microtiter plates. After 3 days, the cells were pulsed with O·5 µCi [3Η] thymidine 
(methyl-T thymidine, from BRIT, Bombay) per well, for 18 h. Cells were harvested by 
an automated cell harvester (PHD cell harvester, Cambridge Technology) onto glass 
fibre discs and deposited in scintillation vials. After drying of discs, 1 ml scintillation 
cocktail was added per vial and these were kept overnight in dark. The incorporated 
[3H] thymidine was determined as counts per million by using a Beckmann or LKB 
Beta liquid scintillation counter. 
 
 
 
2.5 Treatment with proteolytic enzymes coupled to Sepharose beads 
 
Sepharose CL-48 beads were activated by CNBr activation (Puri 1996). Activated 
beads were transferred to the solutions of trypsin or chymotrypsin (2·5 mg/ml) and 
suspension incubated overnight at 4°C. Amount of protein attached to the beads was 
estimated from the protein concentration before and after the coupling reaction. 
Enzyme coupled to beads was estimated to be 1·5 mg (trypsin) and 1·4 mg (chymotryp 
sin) per ml of beads. MHC-AF preparations were incubated with or without enzyme 
coupled beads (80 mg/ml MHC-AF) for 2h at 37°C. After the enzyme reaction, beads
were removed by centrifugation and MHC-AF preparations assessed for biological 
activity. 
 
 
 
3. Results 
 
3.1   Mitogenesis of HPBLs in different media 
 
Activation of HPBLs in presence of Con-Α or PHA was carried out in culture medium 
supplemented with FCS as well as serum free medium. Figure 1 shows the rate of 
proliferation of mitogen activated HPBLs in different culture media. DCCM-1 
and DCCM-2 are two commercially available serum free media. DCCM-1 and 
RPMI-164O supplemented with FCS or BSA have protein in the range of 1–4 mg 
per ml while in DCCM-2 there is only 126 mg of well defined protein. But the rate 
of proliferation of HPBLs in all the media is comparable. Since DCCM-2 medium 
was supportive of the proliferative activity in response to mitogens, we further investi-
gated whether this serum free medium also supported the generation of MHC-AF by 
activated HPBLs. 
 
 
3.2 Generation of MHC-AF activity by HPBLs cultured in DCCM-2 
 
Culture supernatants of HPBLs activated in DCCM-2 medium, were processed 
as described in §2, and their effect on the expression of class I MHC antigens on 
human HR cell line, was examined. Control and supernatant treated tumour cells 
were stained for class I MHC antigens and examined on a flowcytometer. Results 
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Figure 1. Human peripheral blood lymphocyte (Hu-PBL) mitogenesis in different culture 
media. Hu-PBLs were cultured in different media, RPMI-1640 + 2% FCS, RPMI-1640+1
mg/ml BSA, RPMI-1640 + 5% FCS, DCCM-1, and DCCM-2, at 5 x 106 cells per ml, alone, 
or with Con-A (2 µg/ml) or PHA (2 µg/ml). [3H] thymidine pulse was given on day 3 and 
incorporated CPM determined. Mean CPM + SD of three assay wells, are shown. 
 
in figure 2 show that concentrated culture supernatants generated by using DCCM-2 
medium, brought about a marked dose dependent increase in the expression of class 
IMHC antigens on HR cells. MHC-AF activity is thus secreted by HPBLs activated in 
DCCM-2 serum free culture medium. 
 
 
3.3   Molecular weight of MHC-AF 
 
To get an idea about molecular weight of MHC-AF, the Con-Α supernatant was 
concentrated on 30 Κ Amicon membrane. HR cells were treated with Amicon con-
centrated MHC-AF preparation, fall through fraction of MHC-AF through 30 Κ
 
_
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Figure 2. Dose dependent increase in class I MHC expression in HR cell line by human 
MHC-AF. Culture supernatants ofCon-Α activated HPBLs was processed as described in §2. 
HR cells were cultured at 2 × 105 cells/ml for 72 h at 37°C in 5% CO2 incubator, with different 
doses of a post dialysis (0··1 Μ glycine-HCl buffer pH 2··0) MHC-AF preparation, stained for  
class I MHC expression, and analysed on flowcytometer. 
 
membrane, as well as unfractionated MHC-AF, and efect on MHC I expression was 
studied. As seen in figure 3, most MHC-AF activity was retained on Amicon 30 Κ
filter,indicating that the molecular weight of MHC-AF could be above 30 kDa.
 
3.4   Heat susceptibility of human MHC-AF 
 
MHC-AF preparations were incubated at different temperatures for 45 min, and then 
tested for biological activity. Results in figure 4 indicate that treatment at 56°C or 
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Figure 3. Concentration of human MHC-AF on 30 Κ Amicon membrane. Crude human 
MHC-AF was concentrated on 30 Κ Amicon membrane. HR cells were treated with unfrac- 
donated, 30 Κ concentrate and the 30 Κ fall through preparations of MHC-AF, all at 25 % v/v. 
After 3 days incubation at 37°C in 5% CO2 incubator, HR cells were stained for class I MHC 
antigens and analysed on flowcytometer. 
 
above for 45 min abrogated the biological activity of MHC-AF. MHC-AF activity is 
therefore heat labile. 
 
 
 
3.5    Sensitivity of MHC-AF to proteolytic enzymes 
 
In order to examine the susceptibility of MHC-AF activity to proteolytic enzymes, 
MHC-AF preparations treated with trypsin and chymotrypsin were tested for biologi 
cal activity. Presence of proteolytic enzymes in the test preparations was however 
found to interfere with MHC-AF bioassay. In order to overcome this problem, we 
treated the MHC-AF preparations with proteolytic enzymes trypsin and chymotrypsin 
coupled to Sepharose beads (Puri 1996), and the beads were removed by centrifugation 
prior to bioassay. Treatment of MHC-AF with proteolytic enzymes resulted in a loss of 
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Figure 4.   Heat susceptibility of MHC-AF. Aliquotes of MHC-AF preparation were incu-
bated at various given temperatures for 45 min, and examined for biological activity as 
described in legend to figure 2.
 
biological activity (figure 5). These results indicate that the MHC-AF molecule is 
proteinic in nature. 
 
 
4. Discussion 
 
A soluble factor which induces an augmented expression of class I MHC antigens on 
a variety of tumour cell lines, is known to be released by mitogen activated lymphocytes 
in the rat (Saxena 1987; Saxena et al 1988), mouse (Saxena et al 1992) and the human 
66 Aparna Raval, Niti Puri and R Κ Saxena 
 
 
Figures 5.  Susceptibility of MHC-AF to treatment with proteolytic enzymes. MHC-AF
preparations were treated with trypsin or chymotrypsin enzymes coupled to sepharose beads 
for 120 min, at 37°C. Enzyme coupled beads were removed by centrifugation and the 
MHC-AF preparations were assayed for biological activity as described in legend to figure 2. 
 
systems (Saxena et al 1992, 1996). The factor was initially identified by its property of 
inducing resistance to NK cell mediated lysis, in tumour cell lines (Saxena et al 1988). 
For this reason, the factor was called NK-RIF (NK-resistance inducing factor). Further 
studies indicated that the NK- RIF preparations were potent activators of expression of 
class I MHC antigens on tumour cells (Saxena et al 1988,1989). Since we now routinely 
use the MHC activation as a basic bioassay for this activity, the factor is now referred to 
as MHC-AF (MHC I activating factor) (Saxena et al 1996). We have elsewhere 
provided detailed accounts of properties of MHC-AF, its purification from different 
sources and its characterization (Saxena 1987; Saxena et al 1988,1996). 
Since MHC-AF appears to be a hitherto unknown cytokine, it is of great interest to 
isolate this cytokine and determine its amino acid sequence. Attaining this objective 
has however posed considerable difficult. Cytokines are released in a very low 
concentration in the culture supernatants, ranging from few pg to few ng/ml. The 
culture medium in which HPBLs are cultured contains FCS which has a very high 
concentration of protein (about 6Omg/ml). RPMI-1640 supplemented with 5% FCS 
has 3 mg of protein per ml. Hence to purify a few ng of protein from Con-Α supernatant 
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containing such high amount of protein is almost impossible. To tackle this problem we 
have tried a variety of culture media which are either low in protein contents or are 
altogether serum free. Before such media are used for generating large amounts of 
MHC-AF, it is crucial to select the most suitable low protein culture medium and 
demonstrate that MHC-AF is indeed produced in such medium. This has been the 
basic aim of the present study. We first attempted to compare the mitogen induced 
proliferative response in several test media. Results of these experiments indicate that 
the proliferative response of HPBls in different test media was similar. Of the culture 
media examined, DCCM-2 had minimum amount of protein, only 126 mg/ml, and even 
these proteins are defined (BSA 100 µg/ml; transferrin 25 µg/ml and insulin 1 µg/ml). 
Using such a culture medium for the generation of MHC-AF, ofers several advantages. 
Firstly, the overall amount of irrelevant proteins in crude supernatants is reduced 
almost 25-fold (as compared to culture medium containing 5% FCS), making it easy to 
process larger batches of culture supernatants. Moreover, since the culture medium 
proteins are well defined, it is easy to remove these by devising suitable strategies. This 
is very difficult in case of FCS proteins which represent an extremely complex mixture 
of a large number of proteins. 
Our further experiments indicated that MHC-AF was secreted by activated HPBLs 
in DCCM-2. Partial characterization of MHC-AF secreted in DCCM-2 medium 
indicated that the activity is very similar to that isolated from FCS containing culture 
media (Saxena et al 1996). Thus both activities, are resistant to pH 2.0 treatment, have 
a molecular weight above 30 kDa. Efects of heat and proteolytic enzyme treatment on 
the activity of human MHC-AF had not been reported before, and the present studies 
indicate that human MHC-AF is susceptible to both treatments. 
A major hurdle in the purification of human MHC-AF has been the presence of 
overwhelming amount of a large number of irrelevant FCS proteins in MHC-AF 
preparations. Standardization of  use of serum free medium for the generation of human 
MHC-AF is expected to simplify the purification of this activity to homogeneity. 
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